1365993-15-2

Basic information

• Product Name: tert-butyl 3-chloro-4-(4-chlorothiazolo[5,4-c]pyridin-2-yl)-5-fluorophenylcarbamate
• Synonyms: tert-butyl 3-chloro-4-(4-chlorothiazolo[5,4-c]pyridin-2-yl)-5-fluorophenylcarbamate
• CAS NO: 1365993-15-2
• Molecular Weight: 414.287
• Mol File: 1365993-15-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl 3-chloro-4-(4-chlorothiazolo[5,4-c]pyridin-2-yl)-5-fluorophenylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3-chloro-4-(4-chlorothiazolo[5,4-c]pyridin-2-yl)-5-fluorophenylcarbamate(1365993-15-2)
• EPA Substance Registry System: tert-butyl 3-chloro-4-(4-chlorothiazolo[5,4-c]pyridin-2-yl)-5-fluorophenylcarbamate(1365993-15-2)

Safety Data

• Hazardous Substances Data: 1365993-15-2(Hazardous Substances Data)

Upstream product

• 1365993-34-5 2-chloro-6-fluoro-4-iodo-benzoyl chloride 
• 1365993-13-0 2-chloro-N-(2-chloro-3-fluoropyridin-4-yl)-6-fluoro-4-iodobenzamide 
• 1365993-12-9 2-chloro-6-fluoro-4-iodobenzoic acid 
• 1365993-11-8 methyl 2-chloro-6-fluoro-4-iodobenzoate 
• 1365993-10-7 methyl 4-amino-2-chloro-6-fluorobenzoate 
• 1365993-09-4 methyl 4-(tert-butoxycarbonylamino)-2-chloro-6-fluorobenzoate 
• 1000572-88-2 2,5-dibromo-1-chloro-3-fluorobenzene 
• 1354223-71-4 tert-butyl (2-chloro-3-fluoropyridin-4-yl)carbamate 
• 1227577-03-8 2-chloro-3-fluoro-pyridin-4-ylamine 
• 1258298-26-8 3-chloro-5-fluoro-4-(methoxycarbonyl)benzoic acid 
• 1258298-25-7 dimethyl 2-chloro-6-fluoroterephthalate 
• 4248-19-5 tert-butyl carbazate 
• 1365993-14-1 4-chloro-2-(2-chloro-6-fluoro-4-iodophenyl)thiazolo[5,4-c]pyridine 
• 628691-93-0 2-chloro-3-fluoro-pyridine-4-carboxylic acid 

Downstream Products

• 1365990-90-4 2-(4-amino-2-chloro-6-fluorophenyl)-N-(6-methylpyrimidin-4-yl)thiazolo[5,4-c]pyridin-4-amine 

Relevant articles and documents

AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

Provided are compounds of Formula I, stereoisomers, tautomers, solvates, prodrugs and pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R4 and R5 are defined herein, a pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, methods of using the compound or composition in therapy, and methods of 5 manufacturing a compound of Formula I